Highlights:
-ASTRAL trial results show no benefit for renal artery stenting
-Cutting balloon no better than angioplasty
-Setback for drug elution in the periphery as STRIDES follows SIROCCO
-Profile: Roy Greenberg
[pdfviewer width=”100%” height=”940px” beta=”true”]https://vascularnews.com/wp-content/uploads/sites/7/2016/02/44-Vascular-Europe_low-res.pdf[/pdfviewer]
